Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
258.65
+4.96 (1.96%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 204.83 | 89.16 | 10.93 | -139.98 | -69.57 | Upgrade
|
| Depreciation & Amortization | 2.45 | 3.21 | 4.81 | 3.39 | 2.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -100 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.45 | -7.78 | -7.28 | 0.1 | - | Upgrade
|
| Stock-Based Compensation | 54.51 | 49.13 | 39.93 | 33.23 | 15.32 | Upgrade
|
| Other Operating Activities | -18.06 | 4.15 | 1.32 | 0.03 | 1.04 | Upgrade
|
| Change in Accounts Receivable | -22.12 | -62.71 | -42.04 | - | - | Upgrade
|
| Change in Inventory | -6.29 | -11.91 | -4.48 | - | - | Upgrade
|
| Change in Accounts Payable | 0.83 | 1.01 | -0.1 | -1.25 | 0.71 | Upgrade
|
| Change in Income Taxes | -12.39 | -1.62 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 3.55 | 60.76 | 8.09 | 3.91 | 1.79 | Upgrade
|
| Operating Cash Flow | 200.87 | 123.42 | -88.8 | -100.57 | -47.94 | Upgrade
|
| Operating Cash Flow Growth | 62.75% | - | - | - | - | Upgrade
|
| Capital Expenditures | -11.95 | -4.24 | -11.8 | -52.98 | -68.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.44 | - | 100 | - | - | Upgrade
|
| Investment in Securities | -46.9 | -159.2 | -5.56 | -61.1 | -158.43 | Upgrade
|
| Investing Cash Flow | -58.42 | -163.44 | 82.64 | -114.08 | -226.77 | Upgrade
|
| Issuance of Common Stock | 22.66 | 32.4 | 203.5 | 36 | 355.65 | Upgrade
|
| Repurchase of Common Stock | -13.96 | -5.39 | -0.75 | -0.65 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -7.96 | Upgrade
|
| Financing Cash Flow | 8.71 | 27.01 | 202.75 | 35.35 | 347.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.29 | -0.46 | -0.16 | -0.04 | - | Upgrade
|
| Net Cash Flow | 151.44 | -13.46 | 196.43 | -179.35 | 72.98 | Upgrade
|
| Free Cash Flow | 188.91 | 119.18 | -100.6 | -153.55 | -116.27 | Upgrade
|
| Free Cash Flow Growth | 58.51% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 48.55% | 41.02% | -198.43% | - | - | Upgrade
|
| Free Cash Flow Per Share | 6.31 | 4.01 | -3.63 | -6.02 | -5.24 | Upgrade
|
| Cash Income Tax Paid | 15.67 | 5.67 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 93.93 | 92.99 | -74.54 | -90.02 | -85.35 | Upgrade
|
| Unlevered Free Cash Flow | 93.93 | 92.99 | -74.54 | -90.02 | -84.41 | Upgrade
|
| Change in Working Capital | -36.42 | -14.46 | -38.52 | 2.66 | 2.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.